S. K. Tripathi, R. K. Sahoo, and B. K. Biswal,"Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells", Naunyn-Schmiedeberg's Archives of Pharmacology, Springer, January 2024, https://doi.org/10.1007/s00210-024-02965-4       Article

M. Panda, S. Biswal, and B. K. Biswal,"Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-ß-catenin axis", Molecular Biology Reports, vol.51, Springer, April 2024, https://doi.org/10.1007/s11033-024-09477-7       Article

R. K. Sahoo, S. K. Tripathi, S. Biswal, M. Panda, A. S. Mathapati, and B. K. Biswal,"Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics", Biotechnology Journal, Wiley, January 2024, DOI: 10.1002/biot.202300370       Article

S. K. Patra, R. K. Sahoo, S. Biswal, S. S. Panda, and B. K. Biswal,"Enigmatic Exosomal Connection in Lung Cancer Drug Resistance", Molecular Therapy-Nucleic Acids, vol.35, Cell Press, March 2024, https://doi.org/10.1016/j.omtn.2024.102177       Article

S. S. Panda, R. K. Sahoo, S. K. Patra, S. Biswal, and B. K. Biswal,"Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance", Drug Discovery Today, Elsevier, June 2024, https://doi.org/10.1016/j.drudis.2024.104061       Article

S. Biswal, M. Panda, R. K. Sahoo, S. K. Tripathi, and B. K. Biswal,"Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer", Archives of Oral Biology, vol.151, Elsevier, July 2023, https://doi.org/10.1016/j.archoralbio.2023.105697       Article

S. Mund, K. Singh, M. Panda, B. K. Biswal, U. Subuddhi, and V. S. Kumar,"Thiabendazole: a new class of antenna core structure for multifunctional trivalent organo-europium (EuIII) complexes", Journal of Materials Chemistry C, RSC, June 2022, DOI https://doi.org/10.1039/D2TC01078J       Article

S. Kanttripathi, R. K. Sahoo, and B. K. Biswal,"SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance", Drug Discovery Today, Elsevier 2022, https://doi.org/10.1016/j.drudis.2022.05.022       Article

M. Panda and B. K. Biswal,"Evodiamine inhibits stemness and metastasis by altering the SOX9–ß-catenin axis in non-small-cell lung cancer", Journal of Cellular Biochemistry, Wiley 2022, https://doi.org/10.1002/jcb.30304       Article

M. Panda, S. K. Tripathi, G. Zengin, and B. K. Biswal,"Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers.", Cell Biology and Toxicology, Springer, September 2022, 10.1007/s10565-022-09772-8       Article